Fig. 9.
Fig. 9. Effect of PKC activation or inhibition on thrombin- or ADP-induced intracellular Ca2+-transients in human erythroid progenitors. (A) The PKC inhibitor BIM (30 μmol/L) markedly enhanced thrombin (2 U/mL)- or ADP (10 μmol/L)-evoked cellular Ca2+-release. (B) Stimulation of PKC with PMA (10 nmol/L) abolished the effect of thrombin and of ADP. (C) Addition of EGTA (4 mmol/L) to the experimental medium. Ca2+-release from internal stores by thrombin or ADP was similarly blocked by PKC activation. Results are representative for two to eight independent experiments.

Effect of PKC activation or inhibition on thrombin- or ADP-induced intracellular Ca2+-transients in human erythroid progenitors. (A) The PKC inhibitor BIM (30 μmol/L) markedly enhanced thrombin (2 U/mL)- or ADP (10 μmol/L)-evoked cellular Ca2+-release. (B) Stimulation of PKC with PMA (10 nmol/L) abolished the effect of thrombin and of ADP. (C) Addition of EGTA (4 mmol/L) to the experimental medium. Ca2+-release from internal stores by thrombin or ADP was similarly blocked by PKC activation. Results are representative for two to eight independent experiments.

Close Modal

or Create an Account

Close Modal
Close Modal